Use of antihypertensive drugs generates pressure-packed debate in COVID-19 eraResearchers have been trying to understand a possible link between blood pressure medications and COVID-19 Antihypertensive deprescribing may be possible in some older patients with hypertensionNo substantial change in short-term blood pressure control, but long-term clinical outcomes uncertain 2020 Canadian hypertension guidelines now available, with separate guidelines for managing resistant cases Provide expert guidance on the prevention, diagnosis, risk assessment and treatment of hypertension in adults and children Hypertension professional certification program for pharmacists now available Hypertension Canada program provides pharmacists with knowledge and confidence to identify and manage patients with hypertension Bristol-Myers Squibb discontinues Coumadin brand of warfarin Generic alternatives still marketed, but some strengths of one generic product currently in short supply No mask required: Virtual care ideal for CV risk management Chlorthalidone not preferred over hydrochlorothiazide for hypertension treatment Study finds no difference in cardiovascular benefits, but greater risk of renal and electrolyte abnormalities with chlorthalidone No proof that NSAIDs, ACE inhibitors or angiotensin II blockers can worsen the effects of COVID-19 Professional organizations issue statements to counteract misinformation circulating in the media and on social media Watch for calcium channel blocker–loop diuretic prescribing cascade in older hypertensive patients Ontario study finds higher incidence of loop diuretic prescribing in older adults started on CCBs compared to ACEIs, ARBs or other meds Study finds 'stunning' lack of research into women's heart health A new review of the existing research into women's cardiovascular disease has uncovered what the authors call a "stunning'' lack of information about how women are affected. First Previous 22 23 24 25 26 Next Last
